Jolly Thomas

Jolly Thomas

Auto-generated profile, based on publicly available information

Jolly Thomas

Freie Universität Berlin, Institute of Pharmacy, Biopharmaceuticals, Berlin, Germany

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2026 in npj Viruses
Verified
Journal Article
Open access
PDF file
JTJolly Thomas
Jolly Thomas
CNChristoph André Nilius
Christoph André Nilius
LMLeon Matis
Leon Matis
SSSabrina Schnur
Sabrina Schnur
AHAnja Himmelstein
Anja Himmelstein
DLDaniel Christian Lauster
Daniel Christian Lauster
The nasal mucosa is an important site of influenza virus entry and early replication, yet approved antivirals are not designed for nasal delivery. This Review summarizes antiviral strategies suitable for nasal administration and evaluates animal and human-relevant models for their development. We discuss route-specific formulation and regulatory requirements and propose a translational framework integrating in vitro, ex vivo and microphysiological systems with targeted in vivo studies to reduce animal use.